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Abstract
Background: Sudan is a fragile developing country, with a low expenditure on health. It has been subjected to
ongoing conflicts ever since 1956, with the Darfur crisis peaking in 2004. The conflict, in combination with the weak
infrastructure, can lead to poor access to healthcare. Hence, this can cause an increased risk of infection, greater
morbidity and mortality from tuberculosis (TB), especially amongst the poor, displaced and refugee populations.
This study will be the first to describe TB case notifications, characteristics and outcomes over a ten-year period in
Darfur in comparison with the non-conflict Eastern zones within Sudan.
Methods: A cross-sectional review of the National Tuberculosis Programme (NTP) data from 2004 to 2014
comparing the Darfur conflict zone with the non-conflict eastern zone.
Results: New case notifications were 52% lower in the conflict zone (21,131) compared to the non-conflict zone
(43,826). Smear-positive pulmonary TB (PTB) in the conflict zone constituted 63% of all notified cases, compared to
the non-conflict zone of 32% (p < 0.001). Extrapulmonary TB (EPTB) predominated the TB notified cases in the non-
conflict zone, comprising 35% of the new cases versus 9% in the conflict zone (p < 0.001). The loss to follow up
(LTFU) was high in both zones (7% conflict vs 10% non-conflict, p < 0.001) with a higher rate among re-treatment
cases (12%) in the conflict zone. Average treatment success rates of smear-positive pulmonary TB (PTB), over ten
years, were low (65-66%) in both zones. TB mortality among re-treatment cases was higher in the conflict zone (8%)
compared to the non-conflict zone (6%) (p < 0.001).
Conclusion: A low TB case notification was found in the conflict zone from 2004 to 2014. High loss to follow up
and falling treatment success rates were found in both conflict and non-conflict zones, which represents a
significant public health risk. Further analysis of the TB response and surveillance system in both zones is needed to
confirm the factors associated with the poor outcomes. Using context-sensitive measures and simplified pathways
with an emphasis on displaced persons may increase access and case notification in conflict zones, which can help
avoid a loss to follow up in both zones.
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Background
Conflicts impact health infrastructure and human
resources, which can hinder disease prevention and con-
trol measures. This escalates the burden of communic-
able diseases, such as tuberculosis (TB) [1, 2]. In
addition, conflicts cause the displacement of populations
and impair access to healthcare. This can increase TB
transmission, worsen patient outcomes and lead to
increasing rates of drug resistance [3, 4]. A study
conducted in Nepal found that the poor uptake of TB
services was due to war-associated factors [1]. Further-
more, high treatment initiation delays and self-treatment
have also been observed in the Somali conflict region of
Ethiopia [5]. Displaced populations and refugee settle-
ments are frequently exposed to TB risk factors, which
can lead to increased transmission. An example is in
Lebanon, where a 27% rise in TB incidence was attrib-
uted to the increase in the Syrian refugee population [6].
Likewise, a study in El Salvador reported the incidence
rate of TB among internally displaced persons (IDPs) to
be three times higher than the reported rate across the
rest of the country [7]. Furthermore, refugees and IDPs
are at a higher risk of acquiring multi-drug resistant
(MDR) TB due to treatment interruption [8, 9]. TB
associated mortality has been reported to be higher in
conflict zones, as demonstrated by a study from Guinea
Bissau that found TB mortality to be three times higher
among conflict cohorts in comparison to non-conflict
cohorts [10]. A study from Kenya has shown that TB
caused 20% more deaths within children aged 5 years
and younger within the internally displaced population,
in comparison with the children of regular residents
[11]. TB was attributed to the deaths of approximately
26% of adult IDPs in Somalia and 38% to 50% of all
deaths among adult refugees in refugee camps in eastern
Sudan [4].
Sudan is an extremely turbulent country that has suf-
fered from years of civil conflicts, including the North--
South and Darfur crises [12]. Sudan has a low health
expenditure (6.2% of GDP) and has an estimated TB in-
cident rate of 117 per 100,000 individuals [13]. Notified
TB cases have remained relatively constant over the past
decade, within the range of 19,817 to 22,097. Moreover,
Sudan has a low human immunodeficiency virus (HIV)
prevalence, which was reported to be 0.3% as of 2015.
However, the prevalence of MDR TB, as reported by
Sudan’s National TB programme (NTP) in 2012, was 19%
in re-treatment cases and 1.8% in new cases [13]. Another
study in north-eastern Sudan reported an MDR preva-
lence of 6% among new TB cases [14].
The Darfur conflict officially started in 2003, but
clashes flared with a greater intensity in 2004, leading to
a humanitarian crisis. There have been approximately
1.9 million IDPs since the beginning of the conflict. The
highest levels of violence were experienced in 2014 when
more than 430,000 people were newly displaced. There
have also been reports of deprived health situations,
prevalent TB risk factors, low primary health care (PHC)
coverage, inadequate health system accessibility and de-
pleted human resources within the Darfur region [15].
Data associated with TB in Darfur are limited, and there
is an ever-increasing need to address this within the vul-
nerable conflict-ridden population. To our knowledge,
there are no studies analyzing TB data, over a 10-year
period, at a national level within Sudan. In particular,
there has not been a comparison between a conflict zone
and a non-conflict zone within Sudan. Our hypothesis is
that conflicts negatively affect TB prevention and control
measures. This study aims to compare overall TB case
notifications, treatment outcomes and trends between
the conflict region of Darfur and the non-conflict region
of eastern Sudan from 2004 to 2014, to determine the
TB control status in the conflict zone.
Methods
Study design
This is a descriptive cross-sectional review of Sudan’s
NTP surveillance aggregated data from 2004 to 2014,
within a conflict zone (Darfur) and a non-conflict zone
(Eastern Sudan).
General setting
Sudan is a Sub-Saharan African country with an esti-
mated population of 40 million. It is ranked at 167 out
of 188 countries in the Human Development Index
(HDI) and has 4.8 million people needing humanitarian
assistance because of conflict, environmental and food
insecurity factors [16].
Specific setting
The Darfur conflict zone is a border region that covers
an area of 493,180 km2 in western Sudan. It has an esti-
mated population of six million people, including five
states (North, West, South, East and Central Darfur).
The conflict has caused an internal displacement of
people, of which at least 60% are children living in
camps. It has led to Darfur having approximately
140,000 refugees [17].
The non-conflict zone is a border region in eastern
Sudan that covers an area of 324,773 km2. It includes
three states (Kassala, Gadarif and the Red Sea) with a
combined population of approximately 5 million and has
not experienced any conflict during 2004-2014. There
are over 135,000 refugees and asylum seekers residing in
camps [17].
Two zones were chosen for this study to examine the
hypothesis that conflicts have a negative impact on TB
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indicators. The zones were selected because of their
similarities, which are as follows:
 A mixed population of settled peasant and nomadic
herders
 Prevalent poverty, famine and inequalities at social
and political levels, including a lack of access to
adequate quality health services
 Widespread inter- and cross-border mobility and
displacement, which increase the risk of communicable
diseases
 Targeted humanitarian response for vulnerable IDPs
and refugees in partnership with local authorities,
State Ministries, United Nations (UN) agencies,
international and national Non-Governmental
Organizations (NGOs)
 Severely compromised health systems
 TB management and surveillance systems
functioning similarly across both zones
TB management and control
TB prevention and control activities are coordinated by
the NTP in both the conflict and non-conflict zones. The
NTP is managed by a central unit located in Khartoum,
with sentinel coordination in each state. Expansion has
been achieved through the decentralisation of diagnosis
and treatment into TB management units (TBMUs). The
services have been integrated into the existing healthcare
system, which includes recording, reporting, training,
supervision and health education. This allows coverage of
an average of 100,000 people per TBMU.
TB laboratory activities are performed in the regular
laboratory network composed of the national reference
laboratory in the capital Khartoum and state quality con-
trol laboratories. They provide cultures and drug suscep-
tibility. TB patients are treated free of charge and in
accordance with the World Health Organization’s
(WHO) recommended Directly Observed Treatment,
Short Course TB control strategy (DOTS). TB services
are provided through health services in hospitals, health
centres, assigned NGOs and health insurance centres
[18]. In the Darfur conflict zone, approximately 81% of
TBMUs are governmental, 9% are run by military troops,
8% by NGOs and the remaining are insurance centres.
In the Eastern zone, approximately 85% of TBMUs are
governmental, 9% are NGOs, 4% are military centres,
and 2% are insurance centres. NGOs are crucial in
strengthening the TB community systems in both zones
by tracing patients lost to follow up, conducting contact
tracing and active case finding. Moreover, they also han-
dle referrals with the help of trained community health
volunteers.
The surveillance system is standard across Sudan, in-
cluding the conflict-associated zones. Data collection
occurs at TBMU’s, which utilise patient cards and regis-
ters, with the reporting of aggregated data to state and
central authorities occurring quarterly. This reporting
gathers information regarding the case, age, gender and
outcomes. MDR TB care is provided in the Abu-Anga
central hospital in the state of Khartoum. In 2013-2014,
a change of NTP management was introduced with
oversight provided by the Communicable and Non-
Communicable Disease Department (CNDC).
Study population
The study included all centrally registered TB patients
from the two study zones, which are Darfur and the
Eastern states, between 2004 and 2014.
Data collection and analysis
The data were validated at various points, including the
point of entry, at the central NTP level, and through in-
spections of registries for missing data and consistency.
Quarterly aggregated data (number of cases per TB type,
age and gender) were reviewed by year and state for con-
flict and non-conflict zones, covering the period of 2004
to 2014. The data were processed before the analysis to
validate the consistency between the total number of TB
cases (new and re-treated), as well as cohort registered
treatment outcomes. The variables that were collected in-
clude the number of registered cases, the epidemiological
characteristics of registered cases (gender and age), the
type and category of TB, and treatment outcomes. Stan-
dardised definitions for these variables were consistent
with the International Union Against Tuberculosis and
Lung Disease (The Union) and the WHO.
Statistical analysis
The data were extracted from the NTP reporting plat-
forms into Microsoft Excel (Microsoft Corp, Redmond,
Washington, USA), computerised and entered in STATA
version 13.0 (Stata Corp, College Station, Texas, USA).
Using descriptive frequency analysis, the demographic
and clinical characteristics, and treatment outcomes
were analysed in relation to the conflict and non-conflict
zones. The data were cross-tabulated using the chi-s-
quare test to examine relationships. A T-test was applied
and a p-value lower than 0.05 was considered significant.
The associated trends comparing conflict and non-
conflict zones were calculated.
Results
Case notification
Between 2004 and 2014 a total of 21,131 new TB cases
were reported in the conflict zone (Darfur) versus
43,826 in the non-conflict zone. There were 1822 noti-
fied TB re-treatment cases from the conflict and 2024
from the non-conflict zone, as shown in Table 1.
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As shown in Fig. 1, the non-conflict zone surpassed
the conflict zone in the number of notified new cases
per year with a range of 4387-3698 versus 2734-1196,
between 2004 and 2014. The average notification rates
of new cases during this time were 88 and 37 per
100,000 population in the non-conflict and conflict
zones respectively. Furthermore, the average notification
rates of re-treatment cases between 2004 and 2014 were
4.5 and 3 per 100,000 population in the non-conflict and
conflict zones respectively.
Demographic characteristics
Of the reported new cases, 10% were in children aged
15 years and younger in the conflict zone, compared to
5% of cases in the non-conflict zone. Age was unre-
corded for 18% and 22% of new TB cases in the conflict
and non-conflict zones respectively. Gender was not
recorded for almost 29% and 30% of the new TB cases
in the conflict and non-conflict zones respectively.
Within the new TB cases there were 6891 (59%) males
and 4844 (41%) females in the conflict zone, compared
to 7921 (62%) males and 4875 (38%) females in the non-
conflict zone (p < 0.001). The data were not disaggre-
gated by age or gender for the re-treatment TB cases in
either zone.
Clinical characteristics
TB type and category
The distribution of tuberculosis types as proportions
among newly notified cases (Table 2) shows that the
new cases with reported diagnosis by TB type and cat-
egory (21,131 conflict, 43,826 non-conflict) were more
smear positive pulmonary TB in the conflict zone (63%)
compared to the non-conflict zone (32%, p < 0.001).
EPTB was the most common type reported in the
non-conflict zone comprising 35% of the new cases, as
shown in Table 2. There was a significant difference in
the overall TB smear negative proportions in the
conflict zone (25%) versus the non-conflict zone (30%,
p < 0.001), as shown in Table 1.
Re-treatment cases constituted 7% and 4% of all notified
cases in the conflict and non-conflict zones respectively.
Table 1 Case notification classification and treatment outcomes of new and re-treatment tuberculosis, TB, cases in conflict and non-
conflict zones in Sudan, 2004-2014
Clinical characteristics (New cases) Conflict zone N = 21,131 (100%) Non-conflict N = 43,826 (100%) p-value
PTB smear positive 13,283 (63) 14,016 (32) < 0.001
PTB smear negative 5309 (25) 12,680 (30) < 0.001
EPTB 1963 (9) 15,378 (35) < 0.001
PTB (not done) 576 (3) 1392 (3) 0.073
Treatment outcomes (New cases) Conflict N = 20,326 n (%) Non-conflict N = 43,826 n (%)
Treatment successa 13,498 (66) 28,645 (65) < 0.001
Died 422 (2) 1124 (3) < 0.001
Treatment failure 139 (1) 156 (< 1) 0.703
LTFU 1379 (7) 4709 (10) < 0.001
Transferred out 592 (3) 2141 (5) 0.001
Not evaluated 4296 (21) 7051 (16) 0.526
Clinical characteristics (Re-treatment cases) Conflict zone N = 1822 (100%) Non-conflict N = 2024 (100%)
After Relapse 912 (50) 1412 (70) 0.005
After LTFUa 669 (37) 314 (16) 0.014
After Failure 155 (8) 148 (7) 0.804
Othersb 86 (5) 150 (7) 0.276
Treatment outcomes (Re-treatment cases) Conflict zone N = 1822 n (%) Non-conflict N = 2024 n (%)
Treatment successa 693 (38) 911 (45) < 0.001
Died 146 (8) 121 (6) < 0.001
Treatment failure 163 (9) 122 (6) < 0.001
LTFU 218 (12) 202 (10) < 0.001
Transferred out 200 (11) 243 (12) 0.986
Not evaluated 402 (22) 425 (21) 0.713
aPTB Pulmonary TB, EPTB Extrapulmonary TB, LTFU Loss to follow up, Treatment success = Cured and treatment completed cases
ball cases that are registered whom their definition is not consistent with other re-treatment definitions
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Among re-treatment cases, 37% were classified as retained
after the LTFU in the conflict zone compared to 16% in
the non–conflict zone (p = 0.014), as seen in Table 1.
Treatment outcomes
The LTFU rates among new cases were 7% and 10% for the
conflict and non-conflict zones, respectively (p = < 0.001),
as shown in Fig. 2. Reported failures among re-treatment
cases were 9% and 6% between 2004 and 2014 for the con-
flict and non-conflict zones respectively (p < 0.001). Treat-
ment success rates (TSR) of new cases averaged 66% in the
conflict zone and 65% in the non-conflict zone between
2004 and 2014 (p < 0.001), as shown in Fig. 3. A steady de-
crease in TSR of all smear-positive PTB cases was observed
from 2010 in both the conflict and non-conflict zones.
Discussion
To the best of our knowledge, this is the first study
describing the notification, characteristics and outcomes
of TB cases, between the Darfur conflict region and the
Eastern non-conflict zones in Sudan over a ten-year
period. Some of the findings are consistent with the
hypothesis that conflicts are likely to have a negative
impact on TB response measures. However, TB control
indicators, including LTFU and treatment success
among new TB cases, were worse in the non-conflict
zone. Protracted conflicts, ongoing humanitarian crises
and associated low expenditure on health are likely to
have exacerbated an already unfavourable condition for
TB control indicators and disease outcomes.
Challenges for TB control within the conflict zone
The study identified a lower number of cases and notifi-
cation rates of new and re-treatment TB in the Darfur
conflict zone. This may reflect a vast and inaccessible
community within the conflict zone and a considerable
gap in the access to healthcare. Poverty and high direct
non-medical costs for the patient can lower accessibility
Fig. 1 New and retreatment case notification in conflict and non-conflict zones in Sudan, 2004-2014















2004 992 (82%) 1497 (36%) 102 (8%) 1456 (35%) 111 (19%) 1262 (30%)
2005 958 (64%) 1461 (39%) 307 (21%) 1198 (32%) 226 (15%) 1077 (29%)
2006 764 (64%) 1338 (36%) 312 (26%) 1302 (35%) 120 (10%) 1058 (29%)
2007 1218 (66%) 1385 (36%) 474 (26%) 1240 (32%) 164 (9%) 1261 (32%)
2008 1740 (75%) 1393 (35%) 365 (16%) 1099 (28%) 198 (9%) 1351 (34%)
2009 1364 (71%) 1292 (33%) 375 (19%) 992 (25%) 157 (8%) 1517 (38%)
2010 1462 (77%) 1259 (29%) 202 (11%) 1218 (28%) 206 (11%) 1731 (39%)
2011 1690 (62%) 1132 (29%) 690 (25%) 831 (22%) 198 (7%) 1652 (43%)
2012 1085 (53%) 1227 (30%) 693 (34%) 932 (23%) 194 (9%) 1678 (41%)
2013 980 (43%) 1066 (26%) 969 (42%) 1083 (26%) 196 (9%) 1695 (41%)
2014 1030 (47%) 966 (24%) 820 (38%) 1329 (33%) 193 (9%) 1456 (36%)
*TB patterns were reported as proportions from the total number of notified new cases each year in the conflict zone and non-conflict zone during 2004-2014
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to care in both conflict and non-conflict zones [19].
Nevertheless, turbulence and insecurity in the conflict
zone may have further negative effects on the access to
healthcare and further exclude communities from timely
TB management. Specifications on socio-economic
status, residency status, and IDP and refugee camps
were not differentiated at the surveillance level. There-
fore, no identification regarding these access-associated
factors could be obtained for those displaced in the
Darfur conflict zone.
There was a very high proportion of smear-positive
PTB, comprising 63% of all newly notified cases in the
conflict zone. This proportion is higher than the 56%
positive results reported among 1797 registered patients
in the seven states of Sudan between 1998 and 2000
[20]. Here, the crucial finding is that the there is a higher
proportion of smear-negative and EPTB cases in the
non-conflict zone compared with the conflict zone. As
there is a reported healthcare gap in Darfur, the low
number of reported EPTB cases in the conflict zones
compared to the non-conflict zones could be attributed
to the lack of capacity in the disrupted zone to execute
adjunctive EPTB diagnosis [15]. This finding needs to be
further analysed with regards to the TB associated symp-
toms and diagnostic criteria measures because this TB
pool could be expanded by conflict associated delay in
seeking care [5, 21].
The identification of all TB disease types in conflict
settings can be improved by strengthening the capacity
of frontline care in tackling presumptive TB and imple-
menting simple and rapid diagnostics. The proportion of
re-treatment cases was 7% of all notified cases in the
conflict zone, which is less than the 16.2% and 9.1%
reported among the IDPs and the settled population in
Khartoum State [22]. There are higher rates of treatment
failure and LTFU among the re-treatment cases in the
Darfur conflict zone compared to the non-conflict
zone. This can increase the risk of drug resistance,
which is particularly serious for displaced populations
who are already exposed to risk factors associated
Fig. 2 Lost to follow up rates among new cases in conflict and non-conflict zones Sudan 20,014-2014: * Lost to follow up rates (LTFU) were calculated
as the total of LTFU/number of registered cases of treatment outcomes * 100 per year in two zones over 2004-2014
Fig. 3 Treatment success rates for pulmonary smear positive tuberculosis in conflict and non-conflict zones of Sudan, 2004-2014. *Treatment success
rates were calculated as totals of cured and completed treatment cases/ number of registered cases of treatment outcomes * 100 per year in two
zones over 2004-2014
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with a poor socio-economic context, which include
the risk of higher HIV prevalence while crossing to
neighbouring countries [23].
Children make up an important demographic in TB
epidemiology, especially those living in poor socio-
economic conditions with low diagnostic capacities [16].
Children constituted 5% and 10% of notified cases in the
non-conflict and conflict zones respectively. This may be
due to the lower cases notified in general within the
conflict zone. These figures are less than the 13%
reported in Ethiopia but within the expected range of
5-15% in low-income countries [24]. The Surveillance
data are not fully disaggregated by age, especially among
re-treatment cases, highlighting a limitation of the TB
programme in addressing childhood TB.
Challenges for TB control within the conflict and
non-conflict zones
We observed high LTFU rates among reported new and
re-treatment cases throughout 2004-2014 in both zones
(7% and 10% in the conflict zone compared to 12% and
10% in the non-conflict zone). High LTFU rates can lead
to increased disease transmission, greater rates of smear
positivity, drug resistance, chronic pulmonary impair-
ment and increased mortality rates [25]. These findings
are supported by the study from Galkayo, which found a
correlation between the 10% LTFU rate in Somalia and
weak health system management [3].
In Botswana, EPTB was found to be significantly asso-
ciated with a higher LTFU, which may explain the high
proportion of EPTB cases of 36% in the newly reported
cases in the non-conflict zone [26]. A study in Ethiopia
has identified living in a rural setting as an independent
predicator for LTFU [27]. The rural predominance, and
peasant and nomadic populations in both zones indicate
the vital need of context-sensitive TB services to reduce
the LTFU in both zones.
The TSR of new cases were satisfactory in both zones
during 2005-2010, and better rates were observed in the
conflict zone. This could be related to the smaller cohort
and the higher proportion of smear-positive cases, where
the cohort is more likely to be more ailing, and therefore
more likely to complete treatment. A comparative study
of treatment outcomes in Khartoum State showed sig-
nificantly higher success rates among the displaced
(74%) compared to settled populations (64%) [22].
However, a steady decrease in the TSR of all smear-
positive PTB cases was observed in both zones from
2010. This is operationally related to the high propor-
tions of unfavourable outcomes, including LTFU and
non-evaluated cases. This deterioration in performance
in 2010 and the subsequent decrease in TSR in 2012
could be related to challenges in data management and
the lack of monitoring at higher surveillance levels.
These pitfalls may hinder sustainable development goals
and exacerbate the TB-poverty-vulnerability cycle, espe-
cially in conflict settings.
Our findings highlight an urgent need of determined
efforts to investigate the associated factors and reasons
behind these sub-optimal parameters in both zones.
There is a need to revise TB control with “context-sensi-
tive” approaches that simplify pathways to care while
improving treatment adherence and tracing strategies.
These efforts are needed in both zones to curb the emer-
ging public health threats related to TB.
A limitation of this study is the dependence on routine
TB aggregated data, which does not allow for the disag-
gregation of socioeconomic specifications, displacement,
and re-treatment cases by age and gender. Additionally,
the lack of data reporting has likely impacted the results
to an uncertain degree, because the surveillance does not
differentiate between non-functioning and zero notifica-
tion centres. The strengths of the study include the ten-
year timespan of the TB data while assuming a steady
population, and surveillance system within both zones.
Conclusions
There were lower case notification rates and lower pro-
portions of EPTB and smear-negative cases in the conflict
zone. However, the TB control indicators, including LTFU
and treatment success among new TB cases were found
to be worse in the non-conflict zone. Further study is
needed to identify determinant factors and causal relations
behind these findings, along with context-tailored strat-
egies that increase case finding and promote improved
treatment outcomes in both conflict and non-conflict
zones. Potential opportunities include the introduction of
rapid diagnostic testing and improved frontline healthcare.
Local communities could strengthen TB case finding,
treatment adherence and contact tracing to avoid LTFU
and improve treatment outcomes. Lastly, the inclusion of
the place of residence and distance specifications in the
surveillance system would support the monitoring of TB
burden and access, especially among displaced, refugee,
and mobile populations.
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